In vitro digestion of curcuminoid-Loaded lipid nanoparticles

Journal of Nanoparticle Research

Volumn 14, Issue 9, 2012, Pages

  Noack, Andreas ^a   Oidtmann, Johannes ^a   Kutza, Johannes ^a   Mäder, Karsten ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Curcumin; Drug release; Drug stability; HPTLC; In vitro digestion; Lipid nanoparticles

Indexed keywords

FLUORESCENCE IMAGING; IMAGING TECHNIQUES; NANOPARTICLES; PARTICLE SIZE; STABILITY; TARGETED DRUG DELIVERY; THIN LAYER CHROMATOGRAPHY; VEGETABLE OILS;

CURCUMIN; DRUG RELEASE; DRUG STABILITY; HPTLC; IN-VITRO DIGESTIONS; LIPID NANOPARTICLES;

CONTROLLED DRUG DELIVERY;

CURCUMIN; PANCREATIN; PEPSIN A; SOLID LIPID NANOPARTICLE; TRIACYLGLYCEROL; TRIMYRISTIN; TRISTEARIN; UNCLASSIFIED DRUG;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DIGESTION; DRUG RELEASE; DRUG STABILITY; FLUORESCENCE IMAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIPID DEGRADATION; PARTICLE SIZE; PRIORITY JOURNAL; STOMACH JUICE; SYNTHESIS;

EID: 84864679347     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-012-1113-0     Document Type: Article

References (56)

1. Abdalla A, Klein S, Mader K (2008) A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: Characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur J Pharm Sci 5:457-464
2. Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, Pandey MK, Shishodia S et al (2006) From traditional Ayurvedic medicine to modern medicine: Identification of therapeutic targets for suppression of inflammation and cancer. Exp Opin Ther Targets 1:87-118 (Pubitemid 43263269)
3. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: Problems and promises. Mol Pharm 6:807-818
4. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB (2008a) Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Lett 1:133-164
5. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, Tharakan ST, Misra K et al (2008b) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 11:1590-1611
6. Basniwal RK, Buttar HS, Jain VK, Jain N (2011) Curcumin nanoparticles: Preparation, characterization, and antimicrobial study. J Agric Food Chem 59(5):2056-2061
7. Bauer E, Jakob S, Mosenthin R (2005) Principles of physiology of lipid digestion. Asian-Australas J Anim Sci 2:282-295 (Pubitemid 40180961)
8. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A (2007) Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): A novel strategy for human cancer therapy. J Nanobiotechnol 5:3
9. Blumer C, Mader K (2005) Isostatic ultra-high-pressure effects on supercooled melts in colloidal triglyceride dispersions. Pharm Res 10:1708-1715
10. Bonnaire L, Sandra S, Helgason T, Decker EA, Weiss J, McClements DJ (2008) Influence of lipid physical state on the in vitro digestibility of emulsified lipids. J Agric Food Chem 10:3791-3797 (Pubitemid 351860186)
11. Boyd BJ (2003) Characterisation of drug release from cubosomes using the pressure ultrafiltration method. 1. Int J Pharm 2:239-247 (Pubitemid 36773921)
12. Bunjes H, Koch MHJ, Westesen K (2000) Effect of particle size on colloidal solid triglycerides. Langmuir 12:5234-5241
13. Chirio D, Gallarate M, Trotta M, Carlotti M, Gaudino E, Cravotto G (2009) Influence of alpha-and gammacyclodextrin lipophilic derivatives on curcumin-loaded SLN. J Incl Phenom Macrocycl Chem 3:391-402
14. Compton DL, Vermillion KE, Laszlo JA (2007) Acyl migration kinetics of 2-monoacylglycerols from soybean oil via 1 H NMR. J Am Oil Chem Soc 4:343-348 (Pubitemid 46931865)
15. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M (2005) Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2:181-190 (Pubitemid 40719616)
16. Fernandez S, Jannin V, Rodier JD, Ritter N, Mahler B, Carrière F (2007) Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. Biochim Biophys Acta 5: 633-640 (Pubitemid 46670793)
17. Fernandez S, Rodier JD, Ritter N, Mahler B, Demarne F, Carriè re F, Jannin V (2008) Lipolysis of the semi-solid selfemulsifying excipient Gelucire 44/14 by digestive lipases. Biochim Biophys Acta 8:367-375
18. Fureby AM, Virto C, Adlercreutz P, Mattiasson B (1996) Acyl group migrations in 2-monoolein. Biocatal Biotransform 2:89-111 (Pubitemid 126714543)
19. Golding M, Wooster TJ (2010) The influence of emulsion structure and stability on lipid digestion. Curr Opin Colloid Interface Sci 1-2:90-101
20. Gupta V, Aseh A, Ríos CN, Aggarwal BB, Mathur AB (2009) Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int J Nanomed 4:115-122
21. Kakkar V, Singh S, Singla D, Kaur IP (2011) Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res 3:495-503
22. Kuntsche J, Mader K (2010) Solid lipid nanoparticles (SLN) for drug delivery. Handbook Mater Nanomed 1:383-396
23. Levy MY, Benita S (1990) Drug release from submicronized o/w emulsion: A new in vitro kinetic evaluation model. Int J Pharm 1-3:29-37
24. Lukyanov AN, Torchilin VP (2004) Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 9:1273-1289 (Pubitemid 38510474)
25. McClements DJ, Li Y (2010) Structured emulsion-based delivery systems: Controlling the digestion and release of lipophilic food components. Adv Colloid Interface Sci 2:213-228
26. Mehnert W, Mader K (2001) Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2-3:165-196
27. Mukerjee A, Vishwanatha JK (2009) Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 10:3867-3875
28. Muller RH, Mehnert W, Lucks JS, Schwarz C, Zur Muhlen A, Meyhers H, Freitas C, Ruhl D (1995) Solid lipid nanoparticles (SLN): An alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 1:62-69
29. Muller RH, Ruhl D, Runge SA (1996) Biodegradation of solid lipid nanoparticles as a function of lipase incubation time. Int J Pharm 1:115-121 (Pubitemid 27039349)
30. Mun S, Decker EA, McClements DJ (2007) Influence of emulsifier type on in vitro digestibility of lipid droplets by pancreatic lipase. Food Res Int 6:770-781 (Pubitemid 46669996)
31. Nguyen TH, Hanley T, Porter CJH, Boyd BJ (2011) Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. J Controlled Release 2:180-186
32. Olbrich C, Muller RH (1999) Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures. Int J Pharm 1:31-39 (Pubitemid 29131440)
33. Olbrich C, Kayser O, Muller RH (2002a) Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)-effect of surfactants, storage time and crystallinity. Int J Pharm 1-2:119-128 (Pubitemid 34310485)
34. Olbrich C, Kayser O, Muller RH (2002b) Enzymatic degradation of dynasan 114 SLN-effect of surfactants and particle size. J Nanopart Res 1:121-129 (Pubitemid 135713409)
35. Patton JS, Carey MC (1981) Inhibition of human pancreatic lipase-colipase activity by mixed bile salt-phospholipid micelles. Am J Physiol Gastrointest Liver Physiol 4: 328-336 (Pubitemid 12252534)
36. Porter CJH, Kaukonen AM, Taillardat Bertschinger A, Boyd BJ, O'Connor JM, Edwards GA, Charman WN (2004) Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride based oral lipid formulations o poorly water soluble drugs: Studies with halofantrine. J Pharm Sci 5:1110-1121 (Pubitemid 38529685)
37. Priano L, Esposti D, Esposti R, Castagna G, De Medici C, Fraschini F, Gasco MR, Mauro A (2007) Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J Nanosci Nanotechnol 10:3596-3601
38. Ptak M, Egret-Charlier M, Sanson A, Bouloussa O (1980) A NMR study of the ionization of fatty acids, fatty amines and N-acylamino acids incorporated in phosphatidylcholine vesicles. Biochim Biophys Acta 2:387-397
39. Rosenblatt KM, Douroumis D, Bunjes H (2007) Drug release from differently structured monoolein/poloxamer nanodispersions studied with differential pulse polarography and ultrafiltration at low pressure. J Pharm Sci 6:1564-1575 (Pubitemid 46953771)
40. Rube A, Klein S, Mader K (2006) Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy. Pharm Res 9:2024-2029
41. Sahu A, Bora U, Kasoju N, Goswami P (2008) Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater 6:1752-1761
42. Schadlich A, Rose C, Kuntsche J, Caysa H, Mueller T, Gopferich A, Mader K (2011) How stealthy are PEG-PLA nanoparticles? An NIR in vivo study combined with detailed size measurements. Pharm Res 8:1-13
43. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MNV (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 3-4:223-230
44. Small DM, Cabral DJ, Cistola DP, Parks JS, Hamilton JA (1984) The ionization behavior of fatty acids and bile acids in micelles and membranes. Hepatology S2:77S-79S (Pubitemid 14018148)
45. Tiyaboonchai W, Tungpradit W, Plianbangchang P (2007) Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 1-2:299-306 (Pubitemid 46756048)
46. Tønnesen HH, Karlsen J (1985) Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z Lebensm Unters Forsch 5:402-404
47. Tønnesen HH, Másson M, Loftsson T (2002) Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int J Pharm 1-2:127-135 (Pubitemid 35245453)
48. Tuli R, Surmak A Jr, Herman JM (2011) Effect of diferuloyl methane (curcumin) on radiation-induced inhibition of proliferation and cytotoxicity of pancreatic cancer cells. J Clin Oncol 4:222
49. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 12:1867-1876
50. Washington C (1990) Drug release from microdisperse systems: A critical review. Int J Pharm 1:1-12 (Pubitemid 20034221)
51. Washington C, Evans K (1995) Release rate measurements of model hydrophobic solutes from submicron triglyceride emulsions. J Controlled Release 3:383-390
52. Wulff-Pérez M, Gálvez-Ruíz MJ, De Vicente J, Martín-Rodrí-guez A (2010) Delaying lipid digestion through steric surfactant Pluronic F68: A novel in vitro approach. Food Res Int 6:1629-1633
53. Yang S, Zhu J, Lu Y, Liang B, Yang C (1999) Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res 5:751-757 (Pubitemid 29227107)
54. Youssef KM, El-Sherbeny MA (2005) Synthesis and antitumor activity of some curcumin analogs. Arch Pharm 4:181-189 (Pubitemid 40733783)
55. Zangenberg NH, Mullertz A, Gjelstrup Kristensen H, Hovgaard L (2001a) A dynamic in vitro lipolysis model: II: Evaluation of the model. Eur J Pharm Sci 3:237-244 (Pubitemid 32884320)
56. Zangenberg NH, Mullertz A, Kristensen HG, Hovgaard L (2001b) A dynamic in vitro lipolysis model: I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci 2:115-122 (Pubitemid 32737533)